Data from Ozanimod Clinical Development Program in Relapsing Forms of...
Data to be presented include analyses of longterm efficacy and safety of ozanimod in adults with relapsing forms of multiple sclerosis and effects on biomarkers of disease activity Celgene Corporation...
View ArticleThe dietmicrobiome connection in inflammatory bowel disease
A change in diet is a goto strategy for treating inflammatory bowel diseases like Crohn's. In dogs with a similar illness researchers tracked specific changes in the microbiome as the pets went into...
View ArticleExperion Holdings Ltd. Signs LOI with the Socit Qubcoise du Cannabis SQDC to...
VANCOUVER BC and MONTREAL QC ACCESSWIRE September 10 2019 Experion Holdings Ltd. TSXV EXP OTCQBEXPFF FRANKFURTMB31 formerly Viridium Pacific Group Ltd today announced that its whollyowned subsidiary...
View ArticleTiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with...
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION 5962014. UPON PUBLICATION OF THE ANNOUNCEMENT...
View ArticleNational Alliance for Caregiving NAC Names Gabriela Prudencio as the...
NAC Works to Bridge Gap Between Research Policy and PracticeWASHINGTON PRWEB September 11 2019 The National Alliance for Caregiving NAC a nonprofit organization dedicated to research and advocacy on...
View ArticleGenentechs Tecentriq Atezolizumab as a FirstLine Monotherapy Helped Certain...
Data will be shared with health authorities globally including the U.S. Food and Drug Administration FDA and European Medicines Agency EMA Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY...
View ArticleHuman medicines European public assessment report EPAR Stelara ustekinumab...
Human medicines European public assessment report EPAR Stelara ustekinumab PsoriasisArthritis PsoriaticCrohn Disease Date of authorisation 15012009 Revision 28 Status Authorised
View ArticleT Cell Surface Glycoprotein CD3 Epsilon Chain T Cell Surface Antigen T3Leu 4...
T Cell Surface Glycoprotein CD3 Epsilon Chain T Cell Surface Antigen T3Leu 4 Epsilon Chain or CD3E Pipeline Review H1 2019SummaryAccording to the recently published report 'T Cell Surface Glycoprotein...
View ArticleCanadian IBD charity updates biosimilar position statement
On 5 September 2019 Crohns and Colitis Canada announced that it had updated its position statement on the use of biosimilars for inflammatory bowel disease IBD. The updated position statement was...
View ArticlePanTheryx Announces Dr. Mehmet Oz to Join its Board of Directors
MD and Emmy awardwinning talk show host Dr. Oz will help advise biotechnology company focused on innovative bovine colostrumbased therapiesPanTheryx a biotechnology company today announced that it has...
View ArticleMorphoSys's Licensee Janssen Submits Biologics License Application to U.S....
MorphoSys&39;s Licensee Janssen Submits Biologics License Application to U.S. FDA of TremfyaR Guselkumab for Treatment of Adults with Active Psoriatic ArthritisPLANEGG MUNICH GERMANY ACCESSWIRE...
View ArticleTiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical...
A breakthrough approach for treatment of autoimmune and inflammatory diseasesTHE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER...
View ArticleMorphoSys's Licensee Janssen Submits Biologics License Application to U.S....
DGAPNews MorphoSys AG Key words Regulatory Admission 16.09.2019 1357 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany September 16 2019MorphoSys's Licensee...
View ArticleIntegrin Alpha 4 Pipeline Review H2 2019 Published by Global Markets Direct...
Integrin Alpha 4 Pipeline Review H2 2019SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 pipeline Target constitutes close to 16 molecules. The latest...
View ArticleIntegrin Beta 7 Pipeline Review H2 2019 Published by Global Markets Direct...
Integrin Beta 7 Pipeline Review H2 2019SummaryIntegrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Integrin beta7 is an integrin protein encoded by the ITGB7 gene. It interacts with the cell...
View ArticleIntercellular Adhesion Molecule 1 Pipeline Review H2 2019 Published by Global...
Intercellular Adhesion Molecule 1 Pipeline Review H2 2019SummaryIntercellular Adhesion Molecule 1 Major Group Rhinovirus Receptor or CD54 or ICAM1 Intercellular Adhesion Molecule 1 ICAM1 is a protein...
View ArticleArcutis Inc.'s Development Program for Eczema
ARQ252 potential to offer "Best in Class" topical JAK therapy Potent and highly selective inhibitor of JAK1 Phase 2b study in adult patients with eczema anticipated to start in the...
View ArticleRisk of Crohn's Disease or UC With AntiTNFa Agents
Is there an increased risk of developing de novo inflammatory bowel disease while under treatment with antiTNFalpha for other chronic inflammatory or immunemediated diseases Alimentary Pharmacology...
View ArticlePredictImmune announces new framework agreement with Cambridge Enterprise to...
The agreement will enable PredictImmune to broaden its product range through the development and commercialisation of a prognostic test for SLE PredictImmune developers of pioneering prognostic tools...
View ArticleArthritis drug provides relief for blood cancer patients
A simple arthritis drug could be an effective lowcost solution to treat patients with blood cancers such as polycythemia vera PV and essential thrombocythemia ET according to a study led by Dr Martin...
View Article